Tevogen (TVGN) Times Interest Earned (2023 - 2025)
Tevogen Bio Holdings' (TVGN) quarterly Times Interest Earned came in at -$0.24 in Q4 2025, up 97.63% YoY from -$0.12 in Q4 2024, and up 99.94% on a QoQ basis from -$421.49 in Q1 2025.
Tevogen (TVGN) Times Interest Earned (2023 - 2025) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 3 years of Times Interest Earned data on file, last reported at -$0.24 in Q4 2025.
- Quarterly Times Interest Earned rose 97.63% year-over-year to -$0.24 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$862.2 (down 2270.56% YoY) and the FY2025 annual result came in at -$1.38, up 97.22% from the prior year.
- Times Interest Earned grew to -$0.24 in Q4 2025, from -$421.49 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.24 in Q4 2025 to a low of -$488.44 in Q3 2024.
- A 3-year average of -$141.51 and a median of -$9.17 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned tumbled 6201.29% — and 2025, when it soared 97.63%.
- Tracing TVGN's Times Interest Earned over 3 years: stood at -$6.33 in 2023, then slumped by 62.8% to -$10.3 in 2024, then soared by 97.63% to -$0.24 in 2025.
- The last three Times Interest Earned figures came in at -$0.24 (Q4 2025), -$421.49 (Q1 2025), and -$10.3 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Tevogen | 25.62 Mn | 25.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.24 |
| Mar 31, 2025 | -421.49 |
| Dec 31, 2024 | -10.30 |
| Sep 30, 2024 | -488.44 |
| Mar 31, 2024 | -189.47 |
| Dec 31, 2023 | -6.33 |
| Sep 30, 2023 | -7.75 |
| Mar 31, 2023 | -8.04 |